News Headlines Article

Stem cell industry’s ‘huge development’ in Bay Area
San Francisco Chronicle

Almost three years after a Bay Area company shut down the world’s first clinical trial of a therapy using embryonic stem cells, another local company is reviving the therapy. The treatment drew international attention in 2010, when Geron in Menlo Park began testing it in patients with severe spinal cord injuries. But it scrapped the project a year later because of a lack of funds – a move seen as a major blow to the nascent field.

Commands